Bios failure, 2003 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bios failure, 2003

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Miljenko Zuanic who started this subject	2/19/2003 12:22:26 AM
From: scaram(o)uche	of 13

LONDON, Feb 18 (Reuters) - A new pain drug designed to cause fewer ulcers than conventional medicines failed to show significant benefits in a key clinical test, developer AstraZeneca Plc AZN.L said on Tuesday. The drug, known by the codename AZD3582 and licensed from French firm NicOx The effort from Medinox, MX-1094, phase II trial (phase I trial enrolled 48 subjects) scheduled to begin 1H03........... patft.uspto.gov medinox.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext